Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments... Show more
SNY is expected to report earnings to fall 47.74% to 93 cents per share on July 31
Q2'25
Est.
$0.94
Q1'25
Beat
by $0.12
Q4'24
Beat
by $0.53
Q3'24
Beat
by $0.88
Q2'24
Beat
by $0.84
The last earnings report on April 24 showed earnings per share of $1.79, beating the estimate of $1.67. With 95.95K shares outstanding, the current market capitalization sits at 122.61B.